INDIANAPOLIS (WTHR) — Eli Lilly announced plans Tuesday to sell two of its insulin pens at half price.
The medicines involved are Humalog Mix75/25 KwikPen and Humalog Junior KwikPen.
"Lilly is committed to offering the broadest suite of solutions for people who need help affording their insulin, and our lower-priced insulins are important options," said Mike Mason, president, Lilly Diabetes. "But real change to our reimbursement system is needed. Insurance coverage should ensure no one with diabetes is forced to ration or skip doses for financial reasons."
Both insulin pens will have 50 percent lower list prices compared to the branded versions and will be available by mid-April.
The insulin pens will cost $265.20 for a package of five and be sold under the Insulin Lispro name.
People in the coverage gap of Medicare Part D, the uninsured or those with high-deductible insurance plans could see the most savings.
Eli Lilly said because most insurance plans provide copays for chronic medicines that are lower than the list price, people should ask their pharmacist whether these options reduce their out-of-pocket cost.